Age-related decrease in stimulated glutamate release and vesicular glutamate transporters in APP/PS1 transgenic and wild-type mice

Journal of Neurochemistry

Volumn 105, Issue 3, 2008, Pages 584-594

  Minkeviciene, R ^a   Ihalainen, J ^a   Malm, T ^a   Matilainen, O ^a   Keksa Goldsteine, V ^a   Goldsteins, G ^a   Iivonen, H ^a   Leguit, N ^b   Glennon, J ^b,c   Koistinaho, J ^a   Banerjee, P ^d   Tanila, H ^a,e  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b Solvay Pharmaceuticals Inc   (Netherlands)

^c NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^d Forest Laboratories   (United States)

^e KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Alzheimer's disease; Cortex; Hippocampus; Microdialysis; Spatial memory

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMATE TRANSPORTER; GLUTAMIC ACID; POTASSIUM CHLORIDE; PRESENILIN; SYNAPTOPHYSIN; VESICULAR GLUTAMATE TRANSPORTER;

AGING; AMNESIA; AMYLOID NEUROPATHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; MEMORY CONSOLIDATION; MICRODIALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; SPATIAL MEMORY;

AGING; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ASTROCYTES; BRAIN; DISEASE MODELS, ANIMAL; DOWN-REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOSIS; GLUTAMIC ACID; HUMANS; MALE; MEMORY DISORDERS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PRESENILIN-1; SENILE PLAQUES; SYNAPTIC TRANSMISSION; VESICULAR GLUTAMATE TRANSPORT PROTEIN 1;

MUS; MUS MUSCULUS;

EID: 42449107478     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2007.05147.x     Document Type: Article

References (35)

1. Almeida C. G., Tampellini D., Takahashi R. H., Greengard P., Lin M. T., Snyder E. M. Gouras G. K. (2005) Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses. Neurobiol. Dis. 20, 187 198.
2. Bell K. F., de Kort G. J., Steggerda S., Shigemoto R., Ribeiro-da-Silva A. Cuello A. C. (2003) Structural involvement of the glutamatergic presynaptic boutons in a transgenic mouse model expressing early onset amyloid pathology. Neurosci. Lett. 353, 143 147.
3. Cha J. H., Farrell L. A., Ahmed S. F., Frey A., Hsiao-Ashe K. K., Young A. B., Penney J. B., Locascio J. J., Hyman B. T. Irizarry M. C. (2001) Glutamate receptor dysregulation in the hippocampus of transgenic mice carrying mutated human amyloid precursor protein. Neurobiol. Dis. 8, 90 102.
4. Davies P. Maloney A. J. F. (1976) Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 2, 1403.
5. Etcheberrigaray R., Ito E., Kim C. S. Alkon D. L. (1994) Soluble beta-amyloid induction of Alzheimer's phenotype for human fibroblast K+ channels. Science 264, 276 279.
6. Fonnum F. (1993) Regulation of the synthesis of the transmitter glutamate pool. Prog. Biophys. Mol. Biol. 60, 47 57.
7. Good T. A., Smith D. O. Murphy R. M. (1996) Beta-amyloid peptide blocks the fast-inactivating K+ current in rat hippocampal neurons. Biophys. J. 70, 296 304.
8. Greenamyre J. T. Young A. B. (1989) Excitatory amino acids and Alzheimer's disease. Neurobiol. Aging 10, 593 602.
9. Hsieh H., Boehm J., Sato C., Iwatsubo T., Tomita T., Sisodia S. Malinow R. (2006) AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss. Neuron 52, 831 843.
10. Hyman B. T., Van Hoesen G. W. Damasio A. R. (1987) Alzheimer's disease: glutamate depletion in the hippocampal perforant pathway zone. Ann. Neurol. 22, 37 40.
11. Jankowsky J. L., Fadale D. J., Anderson J. et al. (2004) Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum. Mol. Genet. 13, 159 170.
12. Jorgensen A. B., Dalby N. O., Mork A. Veng L. M. (2007) Presynaptic glutamatergic changes in the APPswe/PS1dE9 mouse model of Alzheimer's disease. Neurodegenerative Dis. 4(Suppl.I): 241.
13. Kirvell S. L., Esiri M. Francis P. T. (2006) Down-regulation of vesicular glutamate transporters precedes cell loss and pathology in Alzheimer's disease. J. Neurochem. 98, 939 950.
14. Li S., Mallory M., Alford M., Tanaka S. Masliah E. (1997) Glutamate transporter alterations in Alzheimer disease are possibly associated with abnormal APP expression. J. Neuropathol. Exp. Neurol. 56, 901 911.
15. Lowe S. L. Bowen. D. M., Francis P. T. Neary D. (1990) Ante mortem cerebral amino acid concentrations indicate selective degeneration of glutamate-enriched neurons in Alzheimer's disease. Neuroscience 38, 571 577.
16. Machova E., Jakubik J., Michal P., Oksman M., Iivonen H., Tanila H. Dolezal V. (2006) Impairment of muscarinic transmission in transgenic APPswe/PS1dE9 mice. Neurobiol. Aging 2006, Nov 29.
17. Malin S. A., Guo W. X., Jafari G., Goate A. M. Nerbonne J. M. (1998) Presenilins upregulate functional K+ channel currents in mammalian cells. Neurobiol. Dis. 4, 398 409.
18. Marutle A., Unger C., Hellström-Lindahl E., Wang J., Puoliväli J., Tanila H., Nordberg A. Zhang X. (2002) Elevated levels of Abeta1-40 and Abeta1-42 do not alter the binding sites of nicotinic receptor subtypes in the brain of APPswe and PS1 double transgenic mice. Neurosci. Lett. 328, 269 272.
19. Masliah E., Alford M., Mallory M., Rockenstein E., Moechars D. Van Leuven F. (2000) Abnormal glutamate transport function in mutant amyloid precursor protein transgenic mice. Exp. Neurol. 163, 381 387.
20. Massieu L. Tapia R. (1997) Glutamate uptake impairment and neuronal damage in young and aged rats in vivo. J. Neurochem. 69, 1151 1160.
21. Montana V., Malarkey E. B., Verderio C., Matteoli M. Parpura V. (2006) Vesicular transmitter release from astrocytes. Glia. 54, 700 715.
22. Nedergaard M., Takano T. Hansen A. J. (2002) Beyond the role of glutamate as a neurotransmitter. Nat. Rev. Neurosci. 3, 748 755.
23. Plant L. D., Boyle J. P., Thomas N. M. et al. (2002) Presenilin-1 mutations alter K+ currents in the human neuroblastoma cell line. SH-SY5Y 13, 1553 1556.
24. Plant L. D., Webster N. J., Boyle J. P., Ramsden M., Freir D. B., Peers C. Pearson H. A. (2006) Amyloid beta peptide as a physiological modulator of neuronal 'A'-type K+ current. Neurobiol. Aging 27, 1673 1683.
25. Procter A. W., Palmer A. M., Francis P. T., Lowe S. L., Neary D., Murphy E., Doshi R. Bowen D. M. (1988) Evidence of glutamatergic denervation and possible abnormal metabolism in Alzheimer's disease. J. Neurochem. 50, 790 802.
26. Savonenko A., Xu G. M., Melnikova T., Morton J. L., Gonzales V., Wong M. P., Price D. L., Tang F., Markowska A. L. Borchelt D. R. (2005) Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities. Neurobiol. Dis 18, 602 617.
27. Segovia G., Porras A., Del Arco A. Mora F. (2001) Glutamatergic neurotransmission in aging: a critical perspective. Mech. Ageing Dev. 122, 1 29.
28. Shemer I., Holmgren C., Min R. et al. (2006) Non-fibrillar beta-amyloid abates spike-timing-dependent synaptic potentiation at excitatory synapses in layer 2/3 of the neocortex by targeting postsynaptic AMPA receptors. Eur. J. Neurosci. 23, 2035 2047.
29. Terry R. D., Masliah E., Salmon D. P., Butters N., DeTeresa R., Hill R., Hansen L. A. Katzman R. (1991) Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30, 572 580.
30. Wilson N. R., Kang J., Hueske E. V., Leung T., Varoqui H., Murnick J. G., Erickson J. D. Liu G. (2005) Presynaptic regulation of quantal size by the vesicular glutamate transporter VGLUT1. J. Neurosci. 25, 6221 6234.
31. Wojcik S. M., Rhee J. S., Herzog E., Sigler A., Jahn R., Takamori S., Brose N. Rosenmund C. (2004) An essential role for vesicular glutamate transporter 1 (VGLUT1) in postnatal development and control of quantal size. Proc Natl. Acad. Sci. USA 101, 7158 7163.
32. Wong T. P., Debeir T., Duff K. Cuello A. C. (1999) Reorganization of cholinergic terminals in the cerebral cortex and hippocampus in transgenic mice carrying mutated presenilin-1 and amyloid precursor protein transgenes. J. Neurosci. 19, 2706 2716.
33. Ye C. P., Selkoe D. J. Hartley D. M. (2003) Protofibrils of amyloid beta-protein inhibit specific K+ currents in neocortical cultures. Neurobiol. Dis. 13, 177 190.
34. Zhang W. Q., Mundy W. R., Thai L., Hudson P. M., Gallagher M., Tilson H. A. Hong J. S. (1991) Decreased glutamate release correlates with elevated dynorphin content in the hippocampus of aged rats with spatial learning deficits. Hippocampus 1, 391 397.
35. Zoia C., Cogliati T., Tagliabue E., Cavaletti G., Sala G., Galimberti G., Rivolta I., Rossi V., Frattola L. Ferrarese C. (2004) Glutamate transporters in platelets: EAAT1 decrease in aging and in Alzheimer's disease. Neurobiol. Aging 25, 149 157.